Lymphatic mapping for image guided radiotherapy in patients with locally advanced cervical cancer, a pilot study

Lymphatic mapping for image guided radiotherapy in patients with locally advanced cervical cancer, a pilot study - LaMA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55075

Enrollment

Registered

2020-06-08

Start date

2020-07-20

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

locally advanced cervical cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Histologically proven locally advanced cervical cancer [FIGO stage IIB-IVA]. >18 years old. Treatment with curative (chemo)radiation. Signed informed consent.

Exclusion criteria

Exclusion criteria: BMI and pregnancy. Administration of the radioactive tracer cannot be ensured properly due to obesity (BMI >35). Patients with tumors in which no circumferential injection of [99mTc]Tc-nanocolloid is possible due to the size or position of the tumor.

Design outcomes

Primary

Measure	Time frame
Is it feasible to perform lymphatic mapping in locally advanced cervical cancer? Is there visualisation of (multiple) lymph nodes in both sides of the tumour?	—

Secondary

Measure	Time frame
Are all visible lymph nodes included in the standard radiotherapy treatment plan? Did all visible lymph nodes receive the intended curative dose?	—

Countries

Netherlands

Outcome results